JP2022552377A5 - - Google Patents
Info
- Publication number
- JP2022552377A5 JP2022552377A5 JP2022522646A JP2022522646A JP2022552377A5 JP 2022552377 A5 JP2022552377 A5 JP 2022552377A5 JP 2022522646 A JP2022522646 A JP 2022522646A JP 2022522646 A JP2022522646 A JP 2022522646A JP 2022552377 A5 JP2022552377 A5 JP 2022552377A5
- Authority
- JP
- Japan
- Prior art keywords
- oncolytic virus
- item
- protein
- virus according
- mutations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962916035P | 2019-10-16 | 2019-10-16 | |
| US62/916,035 | 2019-10-16 | ||
| PCT/US2020/056107 WO2021076982A1 (en) | 2019-10-16 | 2020-10-16 | Modified extracellular enveloped virus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022552377A JP2022552377A (ja) | 2022-12-15 |
| JP2022552377A5 true JP2022552377A5 (enExample) | 2023-09-07 |
| JP7625589B2 JP7625589B2 (ja) | 2025-02-03 |
Family
ID=75538360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022522646A Active JP7625589B2 (ja) | 2019-10-16 | 2020-10-16 | 改変細胞外エンベロープウイルス |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220049228A1 (enExample) |
| EP (1) | EP4045657A4 (enExample) |
| JP (1) | JP7625589B2 (enExample) |
| KR (1) | KR20220082025A (enExample) |
| CN (1) | CN114761562B (enExample) |
| AU (1) | AU2020366456A1 (enExample) |
| CA (1) | CA3151975A1 (enExample) |
| WO (1) | WO2021076982A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023128672A1 (ko) * | 2021-12-29 | 2023-07-06 | 재단법인 아산사회복지재단 | 외피외 바이러스 생산이 증가한 신규한 백시니아 바이러스 변이주 |
| WO2025184411A1 (en) | 2024-02-27 | 2025-09-04 | Calidi Biotherapeutics (Nevada), Inc. | Serum-resistant eev viruses and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2269619A1 (en) * | 2002-08-12 | 2011-01-05 | Jennerex Biotherapeutics ULC | Methods and compositions concerning poxviruses and cancer |
| KR20140122603A (ko) * | 2013-04-10 | 2014-10-20 | 신라젠(주) | 세포외 피막성 백시니아 바이러스의 생성과 관련된 단백질을 코딩하는 폴리뉴클레오티드로 형질전환된 숙주세포 |
| AU2014308648B2 (en) * | 2013-08-22 | 2020-11-12 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Immuno-oncolytic therapies |
| HK1255192A1 (zh) * | 2015-09-08 | 2019-08-09 | Sillajen, Inc. | 表达细胞因子和羧酸酯酶的修饰的溶瘤痘苗病毒及其使用方法 |
| JP7551496B2 (ja) * | 2017-10-31 | 2024-09-17 | カリヴィル イムノセラピューティクス， インコーポレイテッド | 全身送達のためのプラットフォーム腫瘍溶解性ベクター |
-
2020
- 2020-10-16 EP EP20875699.9A patent/EP4045657A4/en active Pending
- 2020-10-16 JP JP2022522646A patent/JP7625589B2/ja active Active
- 2020-10-16 CA CA3151975A patent/CA3151975A1/en active Pending
- 2020-10-16 CN CN202080084795.2A patent/CN114761562B/zh active Active
- 2020-10-16 WO PCT/US2020/056107 patent/WO2021076982A1/en not_active Ceased
- 2020-10-16 KR KR1020227015793A patent/KR20220082025A/ko not_active Ceased
- 2020-10-16 AU AU2020366456A patent/AU2020366456A1/en not_active Abandoned
-
2021
- 2021-10-05 US US17/494,322 patent/US20220049228A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230277639A1 (en) | Personalized vaccine | |
| US20250381237A1 (en) | Oncolytic virus expressing a car t cell target and uses thereof | |
| EP3480307B1 (en) | New genetically-modified vaccinia virus | |
| US20090136917A1 (en) | Systems and methods for viral therapy | |
| US20220056480A1 (en) | Modified orthopoxvirus vectors | |
| Zhang et al. | The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14. 5L inactivation | |
| KR20100110292A (ko) | 폭스바이러스성 온콜리틱 벡터 | |
| JP2020531524A5 (enExample) | ||
| US11344589B2 (en) | Genetically engineered vaccinia viruses | |
| EP4304615A1 (en) | Methods of enhancing diversity of hla haplotype expression in tumors to broaden tumor cell susceptibility to tcr-t therapy | |
| KR20240004764A (ko) | 변형된 mhc 발현을 위한 종양용해성 바이러스 | |
| US20230256057A1 (en) | Treatment of immune depression | |
| Wang et al. | Characterization of an attenuated TE3L-deficient vaccinia virus Tian Tan strain | |
| CA3196813A1 (en) | Novel recombinant vaccinia virus and use thereof | |
| JP7274138B2 (ja) | Ｓｃｒ欠失ワクシニアウイルス | |
| JP2025503721A (ja) | がん治療用免疫刺激タンパク質をコードする組換えオルソポックスウイルスベクター | |
| HK40103886A (zh) | 用於修饰的mhc表达的溶瘤病毒 | |
| WO2024062098A1 (en) | Recombinant pseudocowpox virus encoding an interleukin-12 | |
| HK40122972A (zh) | 编码TGF- β抑制物和IL-12的核酸及其用途 |